13 January 2023 - Daiichi Sankyo today announced the submission of an application for marketing approval of DS-5670 to the ...
9 January 2023 - Commercial price is similar to Pfizer’s plans for after government contracting ends. ...
6 January 2023 - If approved, the vaccine would provide the broadest serotype coverage of any pneumococcal conjugate vaccine in infants ...
5 January 2023 - Breakthrough therapy designation for 24 valent investigational pneumococcal conjugate vaccine candidate based on positive topline proof of ...
28 December 2022 - Pfizer today announced that the US FDA accepted for review a biologics license application for its investigational ...
23 December 2022 - Valneva today announces that it has completed rolling submission of the biologics license application to the ...
22 December 2022 - This is an abbreviated version of the COVID-19 vaccine safety report. ...
21 December 2022 - VidPrevtyn Beta, the COVID-19 vaccine developed by Sanofi, has been authorised by the MHRA. ...
15 December 2022 - To 11 December 2022, the TGA has received 706 reports which have been assessed as likely to ...
19 December 2022 - Medicines Australia welcomes the latest peer-reviewed research paper indicating the rollout of the COVID-19 vaccinations significantly ...
13 December 2022 - Vaccine exclusively delivered with the PharmaJet Stratis needle-free injection system. ...
8 December 2022 - Meningitis Foundation says PHARMAC must make both the meningococcal B and ACWY vaccines available to all ...
9 December 2022 - Today, Health Canada authorised the Pfizer-BioNTech Comirnaty Omicron BA.4/BA.5 bivalent adapted booster for use in children 5 ...
8 December 2022 - VBI Vaccines today announced that Health Canada has approved PreHevbrio [3 antigen hepatitis B vaccine (recombinant)] for ...
9 December 2022 - Pfizer and BioNTech today announced the companies have received fast track designation from the US FDA ...